Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Northwestern Memorial Hospital located at 251 E Huron St, Chicago, IL, 60611 & includes data from NPIs 1497859649, 1831298926
Dexur analyzed Q1 2019 (January to March 2019) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Northwestern Memorial Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 3,377 | 3,229 | ||||||||||
| Surgical | 1,230 | 1,195 | ||||||||||
| Non Surgical | 2,147 | 2,034 | ||||||||||
| Cardiovascular | 680 | 659 | ||||||||||
| General Medicine | 414 | 380 | ||||||||||
| Orthopedics | 380 | 373 | ||||||||||
| Urology | 353 | 346 | ||||||||||
| General Surgery | 338 | 319 | ||||||||||
| Gastroenterology & Endocrinology | 310 | 307 | ||||||||||
| Pulmonology | 246 | 220 | ||||||||||
| Neurology | 222 | 210 | ||||||||||
| Oncology & Hematology | 202 | 186 | ||||||||||
| Spine | 75 | 75 | ||||||||||
| Psychiatry & Mental Disorders | 53 | 53 | ||||||||||
| Colorectal | 51 | 50 | ||||||||||
| Obstetrics & Gynecology | 25 | 25 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 17 | 15 | ||||||||||
| Dermatology | 11 | 11 |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 253: OTHER VASCULAR PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 299: PERIPHERAL VASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Major Cardiovascular Procedures | ||||||||||||
| DRG 270: OTHER MAJOR CARDIOVASCULAR PROCEDURES W MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||
| DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Cardiothoracic Procedures | ||||||||||||
| Hypertension | ||||||||||||
| Permanent Cardiac Pacemaker Implant |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Complications Of Treatment | ||||||||||||
| DRG 920: COMPLICATIONS OF TREATMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 919: COMPLICATIONS OF TREATMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Poisoning And Toxic Effects Of Drugs | ||||||||||||
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| DRG 432: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Postoperative And Post-Traumatic Infections |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||
| Connective Tissue Disorders | ||||||||||||
| Osteomyelitis |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Male Pelvic Procedures | ||||||||||||
| DRG 707: MAJOR MALE PELVIC PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| DRG 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 659: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney Transplant | ||||||||||||
| DRG 652: KIDNEY TRANSPLANT |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
| DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Chest Procedures | ||||||||||||
| Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||
| DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | ||||||||||||
| Pancreas, Liver And Shunt Procedures | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Autologous Bone Marrow Transplant Or T-Cell Immunotherapy | ||||||||||||
| DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Postoperative Or Post-Traumatic Infections With O.R. Procedure | ||||||||||||
| Craniotomy With Major Device Implant Or Acute Complex Cns Pdx | ||||||||||||
| DRG 023: CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PDX WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR CHEMOTHERAPY IMPLANT | ||||||||||||
| Extracranial Procedures |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Disorders Of Biliary Tract | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| Endocrine Disorders | ||||||||||||
| Disorders Of Pancreas Except Malignancy | ||||||||||||
| Inflammatory Bowel Disease | ||||||||||||
| DRG 386: INFLAMMATORY BOWEL DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cholecystectomy |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
| Pulmonary Embolism | ||||||||||||
| DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Bronchitis And Asthma | ||||||||||||
| DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Respiratory System Diagnoses | ||||||||||||
| Interstitial Lung Disease |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cranial And Peripheral Nerve Disorders | ||||||||||||
| DRG 073: CRANIAL AND PERIPHERAL NERVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Respiratory Neoplasms | ||||||||||||
| DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Digestive Malignancy | ||||||||||||
| DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lymphoma And Non-Acute Leukemia | ||||||||||||
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||
| Malignancy Of Hepatobiliary System Or Pancreas |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cervical Spinal Fusion | ||||||||||||
| DRG 472: CERVICAL SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Combined Anterior/Posterior Spinal Fusion | ||||||||||||
| DRG 454: COMBINED ANTERIOR/POSTERIOR SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES | ||||||||||||
| Alcohol/Drug Abuse Or Dependence |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2019 to Mar 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jan 2019 to Mar 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2019 to Mar 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures |